MISGAV, Israel, June 6, 2012 /PRNewswire/ --
Only four weeks after receiving FDA clearance, Stimatix GI Ltd., a portfolio company of The Trendlines Group's Misgav Venture Accelerator, was awarded Best Start-Up Company of 2012 by Israel's Office of the Chief Scientist. Stimatix is a leading developer of low-profile innovative solutions for colostomy management, including the AOS-C2000™.
The Israeli Chief Scientist grants awards every year to the country's best incubator and best incubator company. Nominees are chosen out of 23 technological incubators and more than 400 companies. Stimatix received the award at the Chief Scientist's annual ceremony, which was held on June 5 in Shefayim.
Steve Rhodes, Chairman and CEO of The Trendlines Group, said of Stimatix's achievement: "We are really proud of Stimatix's entire team headed by CEO David Hanuka. This achievement highlights the company's commitment to improving the quality of life for individuals receiving ostomy care, as well as to revolutionizing the entire industry, which hasn't seen significant advancement in care in almost 60 years. The award is also recognition that Misgav's investment strategy works." The Misgav Venture Accelerator was named Israel's best incubator in 2010.
Stimatix is developing the AOS-C1000™ and the AOS-C2000™ as part of its colostomy product line that provides voluntary bowel evacuation and improves the quality of life for people with a stoma.
About Stimatix GI Medical Ltd.
Stimatix GI was founded in June 2009 and is a portfolio company of The Trendlines Group's Misgav Venture Accelerator. Stimatix GI develops innovative management devices for people with stoma intended to improve quality of life. More information at http://www.stimatix-gi.com.
The Trendlines Group (http://www.trendlines.com) establishes, invests in, and develops innovation-based businesses in the medical and agritech fields. Seed-stage investors, Trendlines invests principally through a platform of Israeli government-licensed business accelerators, Misgav Venture Accelerator (http://www.misgav-venture.com) and Mofet Venture Accelerator (http://www.mofet-venture.com). Over the last four years, Trendlines has attracted investments exceeding $140 million.
Dorit Orly +972-(0)52-2525167 | Ofir Shpigel's Media and Public Relations | +972-(0)4-9535030.
SOURCE The Trendlines Group